...
首页> 外文期刊>Journal of Clinical Microbiology >Direct detection of Mycobacterium tuberculosis in sputum by polymerase chain reaction and DNA hybridization.
【24h】

Direct detection of Mycobacterium tuberculosis in sputum by polymerase chain reaction and DNA hybridization.

机译:通过聚合酶链反应和DNA杂交直接检测痰中的结核分枝杆菌。

获取原文
           

摘要

A polymerase chain reaction (PCR) assay for the rapid diagnosis of pulmonary tuberculosis was developed by using oligonucleotide primers to amplify a fragment of IS6110, an insertion sequence repeated multiple times in the chromosome of Mycobacterium tuberculosis. Sediment obtained from sputa processed by the N-acetyl-L-cysteine-NaOH method was suspended in a simple lysis buffer and was heated at 100 degrees C for 30 min prior to amplification. A dUTP-uracil N-glycosylase PCR protocol was used to prevent false-positive test results because of the carryover of products from previous amplification reactions. The 317-bp amplicon was detected by direct gel analysis and Southern blotting and then hybridization with a biotin-labeled internal probe. Hybrid molecules were detected by using a commercially available avidin-alkaline phosphatase-chemiluminescent substrate system (Tropix, Inc., Bedford, Mass.). The analytical sensitivity of the assay was 10 fg of purified mycobacterial DNA. The limits of detection by culture (Middlebrook 7H11 agar and Lowenstein-Jensen medium) and by PCR were equivalent in terminal dilution experiments for organism suspensions and positive sputa. An internal control was used to detect the presence of amplification inhibitors in each negative reaction mixture. DNA was purified from inhibitory specimens by phenol-chloroform extraction and ethanol precipitation. PCR results were compared with results of microscopy and conventional culture for the detection of M. tuberculosis in 313 sputum specimens. There were 124 specimens that were positive for M. tuberculosis by conventional methods and 113 (91%) that were positive by PCR. PCR detected 105 of 110 (95%) of the smear-positive and 8 of 14 (57%) of the smear-negative specimens. There were no false-positive results by PCR (specificity, 100%). This PCR assay innovations that make application of this new technology feasible in clinical microbiology laboratories.
机译:通过使用寡核苷酸引物扩增IS6110片段(一种在结核分枝杆菌染色体中多次重复的插入序列),开发了一种用于快速诊断肺结核的聚合酶链反应(PCR)分析方法。将通过N-乙酰基-L-半胱氨酸-NaOH法处理的痰液中的沉淀物悬浮在简单的裂解缓冲液中,并在扩增前于100摄氏度加热30分钟。 dUTP-尿嘧啶N-糖基化酶PCR方案用于防止假阳性测试结果,因为先前扩增反应中的产物会残留下来。通过直接凝胶分析和Southern印迹检测317 bp的扩增子,然后与生物素标记的内部探针杂交。通过使用市售的抗生物素蛋白-碱性磷酸酶-化学发光底物系统(Tropix,Inc。,Bedford,MA)检测杂合分子。该测定法的分析灵敏度为10 fg纯化的分枝杆菌DNA。通过培养物(Middlebrook 7H11琼脂和Lowenstein-Jensen培养基)和PCR的检测极限在生物体悬浮液和阳性痰的终末稀释实验中是等效的。使用内部对照来检测每种阴性反应混合物中扩增抑制剂的存在。通过苯酚-氯仿提取和乙醇沉淀从抑制性样品中纯化DNA。将PCR结果与显微镜检查结果和常规培养结果进行比较,以检测313个痰标本中的结核分枝杆菌。按照常规方法,有124例结核分枝杆菌呈阳性,而PCR呈阳性的标本为113个(91%)。 PCR检测到110例涂片阳性样本中的105例(占95%)和14例涂片阴性样本中的8例(占57%)。 PCR没有假阳性结果(特异性为100%)。这项PCR分析创新技术使这项新技术在临床微生物学实验室中的应用成为可能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号